Current progress and questions in germline genetics of prostate cancer

Dramatic progress has been made in the area of germline genetics of prostate cancer (PCa) in the past decade. Both common and rare genetic variants with effects on risk ranging from barely detectable to outright practice-changing have been identified. For men with high risk PCa, the application of g...

Full description

Bibliographic Details
Main Authors: William B. Isaacs, Jianfeng Xu
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Asian Journal of Urology
Online Access:http://www.sciencedirect.com/science/article/pii/S2214388218300869
_version_ 1818525117752279040
author William B. Isaacs
Jianfeng Xu
author_facet William B. Isaacs
Jianfeng Xu
author_sort William B. Isaacs
collection DOAJ
description Dramatic progress has been made in the area of germline genetics of prostate cancer (PCa) in the past decade. Both common and rare genetic variants with effects on risk ranging from barely detectable to outright practice-changing have been identified. For men with high risk PCa, the application of genetic testing for inherited pathogenic mutations is becoming standard of care. A major question exists about which additional populations of men to test, as men at all risk levels can potentially benefit by knowing their unique genetic profile of germline susceptibility variants. This article will provide a brief overview of some current issues in understanding inherited susceptibility for PCa. Keywords: Genetic susceptibility, BRCA2, Single-nucleotide polymorphisms, Mutations, Germline genetics, Prostate cancer
first_indexed 2024-12-11T06:05:27Z
format Article
id doaj.art-b17f3186c6934ed4b4de1d8075582d5f
institution Directory Open Access Journal
issn 2214-3882
language English
last_indexed 2024-12-11T06:05:27Z
publishDate 2019-01-01
publisher Elsevier
record_format Article
series Asian Journal of Urology
spelling doaj.art-b17f3186c6934ed4b4de1d8075582d5f2022-12-22T01:18:18ZengElsevierAsian Journal of Urology2214-38822019-01-016139Current progress and questions in germline genetics of prostate cancerWilliam B. Isaacs0Jianfeng Xu1Brady Urological Institute, Johns Hopkins University, School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; Corresponding author.North Shore University Health System, Research Institute, Evanston, IL, USADramatic progress has been made in the area of germline genetics of prostate cancer (PCa) in the past decade. Both common and rare genetic variants with effects on risk ranging from barely detectable to outright practice-changing have been identified. For men with high risk PCa, the application of genetic testing for inherited pathogenic mutations is becoming standard of care. A major question exists about which additional populations of men to test, as men at all risk levels can potentially benefit by knowing their unique genetic profile of germline susceptibility variants. This article will provide a brief overview of some current issues in understanding inherited susceptibility for PCa. Keywords: Genetic susceptibility, BRCA2, Single-nucleotide polymorphisms, Mutations, Germline genetics, Prostate cancerhttp://www.sciencedirect.com/science/article/pii/S2214388218300869
spellingShingle William B. Isaacs
Jianfeng Xu
Current progress and questions in germline genetics of prostate cancer
Asian Journal of Urology
title Current progress and questions in germline genetics of prostate cancer
title_full Current progress and questions in germline genetics of prostate cancer
title_fullStr Current progress and questions in germline genetics of prostate cancer
title_full_unstemmed Current progress and questions in germline genetics of prostate cancer
title_short Current progress and questions in germline genetics of prostate cancer
title_sort current progress and questions in germline genetics of prostate cancer
url http://www.sciencedirect.com/science/article/pii/S2214388218300869
work_keys_str_mv AT williambisaacs currentprogressandquestionsingermlinegeneticsofprostatecancer
AT jianfengxu currentprogressandquestionsingermlinegeneticsofprostatecancer